Description
A non-selective COX inhibitor (IC50s = 0.9-2.7 and 1.5-20 µM, for human COX-1 and COX-2, respectively); reduces inflammation and pain associated with osteoarthritis, rheumatoid arthritis, gout, and ankylosing spondylitis; has increased ex vivo skin permeability over diclofenac (sodium salt),
Formal name: 2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid compd. with N-monoethylethanamine
Synonyms:
Molecular weight: 369.3
CAS: 78213-16-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Arthritis (Non-autoimmune)||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway